Literature DB >> 20803301

Thought disorders among non-demented outpatients with Parkinson's disease: prevalence and associated factors.

Rachel Debs1, Valérie Cochen De Cock, Laurence Nègre-Pagès, Marina Aristin, Anna Senard, Olivier Rascol.   

Abstract

The objectives of the study are to evaluate the prevalence and the associated factors of thought disorders in a large cross-sectional population of non-demented out patients with Parkinson's disease (PD). Four-hundred and nineteen consecutive non-demented PD patients were studied through the DoPaMiP cross-sectional study. Demographic and clinical variables were recorded, including motor and cognitive status, dependency, depressive and anxious symptoms, dysautonomia and sleep disorders. The presence of thought disorders over the past 15 days was assessed by the Unified Parkinson's Disease Rating Scale part I. Patients with and without thought disorders were compared using parametric tests. Logistic regression was applied to significant data. Thought disorders were present in 105 patients (25%) including vivid dreams in 83 (19.8%), benign hallucinations in 17 (4.1%), and hallucinations without insight in 5 (1.2%). No patient had delusion. Patients with thought disorders were more dependent than the others. Thought disorders were associated with longer PD duration, greater UPDRS scores and the presence of motor complications. Conversely, UPDRS tremor sub-score was lower in patients without thought disorders. Thought disorders were also associated with dysautonomia, lower MMSE score, depression and sleep disorders. Logistic regression identified PD duration, lower MMSE score, depressive and dysautonomic signs as independent risk factors. In conclusion, mild thought disorders were present in 25% of non-demented outpatients with PD, but hallucinations were present in 5% only. Thought disorders were associated with PD duration, depressive and dysautonomic symptoms and lower MMSE score.

Entities:  

Mesh:

Year:  2010        PMID: 20803301     DOI: 10.1007/s00702-010-0458-8

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  29 in total

1.  Amantadine in the treatment of Parkinson's disease.

Authors:  R S Schwab; A C England; D C Poskanzer; R R Young
Journal:  JAMA       Date:  1969-05-19       Impact factor: 56.272

2.  Hallucinations, REM sleep, and Parkinson's disease: a medical hypothesis.

Authors:  I Arnulf; A M Bonnet; P Damier; B P Bejjani; D Seilhean; J P Derenne; Y Agid
Journal:  Neurology       Date:  2000-07-25       Impact factor: 9.910

3.  Risk factors for nursing home placement in advanced Parkinson's disease.

Authors:  C G Goetz; G T Stebbins
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

4.  Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study.

Authors:  D Aarsland; J P Larsen; J L Cummins; K Laake
Journal:  Arch Neurol       Date:  1999-05

5.  Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease.

Authors:  Claudio Pacchetti; Raffaele Manni; Roberta Zangaglia; Francesca Mancini; Enrico Marchioni; Cristina Tassorelli; Michele Terzaghi; Maria Ossola; Emilia Martignoni; Arrigo Moglia; Giuseppe Nappi
Journal:  Mov Disord       Date:  2005-11       Impact factor: 10.338

6.  Hallucinations and sleep disorders in PD: six-year prospective longitudinal study.

Authors:  Christopher G Goetz; Joanne Wuu; Linda M Curgian; Sue Leurgans
Journal:  Neurology       Date:  2005-01-11       Impact factor: 9.910

7.  Scales to assess psychosis in Parkinson's disease: Critique and recommendations.

Authors:  Hubert H Fernandez; Dag Aarsland; Gilles Fénelon; Joseph H Friedman; Laura Marsh; Alexander I Tröster; Werner Poewe; Olivier Rascol; Cristina Sampaio; Glenn T Stebbins; Christopher G Goetz
Journal:  Mov Disord       Date:  2008-03-15       Impact factor: 10.338

8.  Mortality and hallucinations in nursing home patients with advanced Parkinson's disease.

Authors:  C G Goetz; G T Stebbins
Journal:  Neurology       Date:  1995-04       Impact factor: 9.910

9.  Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. Prepared by the International Association for the Study of Pain, Subcommittee on Taxonomy.

Authors: 
Journal:  Pain Suppl       Date:  1986

Review 10.  Evolution of cognitive dysfunction in an incident Parkinson's disease cohort.

Authors:  C H Williams-Gray; T Foltynie; C E G Brayne; T W Robbins; R A Barker
Journal:  Brain       Date:  2007-05-29       Impact factor: 13.501

View more
  2 in total

1.  Psychosis in Parkinson's disease without dementia: common and comorbid with other non-motor symptoms.

Authors:  Angela H Lee; Daniel Weintraub
Journal:  Mov Disord       Date:  2012-06-01       Impact factor: 10.338

Review 2.  Studying hallucinations within the NIMH RDoC framework.

Authors:  Judith M Ford; Sarah E Morris; Ralph E Hoffman; Iris Sommer; Flavie Waters; Simon McCarthy-Jones; Robert J Thoma; Jessica A Turner; Sarah K Keedy; Johanna C Badcock; Bruce N Cuthbert
Journal:  Schizophr Bull       Date:  2014-05-21       Impact factor: 9.306

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.